J. Lymp

A. Suzuki, K. Lindor, P. Angulo, 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Hypercapnic acidosis impairs plasma membrane wound resealing in ventilator-injured lungs.

O. Gajic, S. Caples, R. Hubmayr, 2005, American journal of respiratory and critical care medicine.

Postinfusion monitoring costs by site of care for patients with relapsed/refractory large B-cell lymphoma receiving third- or later-line treatment with lisocabtagene maraleucel in the TRANSCEND NHL 001 and OUTREACH trials

A. Nguyen, M. Palomba, J. Lymp, 2021, Leukemia & lymphoma.

Psychological Effects of Hazardous Materials Exposures

J. Russo, P. Roy-Byrne, J. Burgess, 2002, Psychosomatic medicine.

Steroid profiling by tandem mass spectrometry improves the positive predictive value of newborn screening for congenital adrenal hyperplasia.

D. Chace, P. Rinaldo, D. Matern, 2004, The Journal of clinical endocrinology and metabolism.

Multicenter Intestinal Current Measurements in Rectal Biopsies from CF and Non-CF Subjects to Monitor CFTR Function

R. Szczesniak, J. Clancy, S. Donaldson, 2013, PloS one.

Criterion validity of the Short Mood and Feelings Questionnaire and one- and two-item depression screens in young adolescents

D. Tsuang, K. Simpson, M. Tracy, 2010, Child and adolescent psychiatry and mental health.

Colorectal cancer prognosis among patients with inflammatory bowel disease.

R. Goldberg, E. Loftus, P. Limburg, 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Serum Reference Intervals and Diagnostic Ranges for Free κ and Free λ Immunoglobulin Light Chains: Relative Sensitivity for Detection of Monoclonal Light Chains

J. Katzmann, R. Kyle, R. Clark, 2002 .

Clinical Features and Outcome

T. Hartman, H. Lee, J. Ryu, 2017 .

Familial idiopathic pulmonary fibrosis: clinical features and outcome.

T. Hartman, H. Lee, J. Ryu, 2005, Chest.

Long-term treatment with oral N-acetylcysteine: affects lung function but not sputum inflammation in cystic fibrosis subjects. A phase II randomized placebo-controlled trial.

C. Goss, J. Clancy, L. Herzenberg, 2015, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains.

J. Katzmann, R. Kyle, R. Clark, 2002, Clinical chemistry.

Reduction in apolipoprotein-mediated removal of cellular lipids by immortalization of human fibroblasts and its reversion by cAMP: lack of effect with Tangier disease cells.

A J Mendez, C. Halbert, A. Mendez, 1999, Journal of lipid research.

The Value of Serum CA 19-9 in Predicting Cholangiocarcinomas in Patients with Primary Sclerosing Cholangitis

G. Gores, N. LaRusso, K. Lindor, 2005, Digestive Diseases and Sciences.

Evaluation Of Two Phase II Blinded and Placebo-Controlled Studies Of Nebulized Liposomal Amikacin (Arikace") In The Treatment Of Cystic Fibrosis Patients With Pseudomonas Aeruginosa Lung Infection

C. Goss, J. Clancy, L. Saiman, 2010, ATS 2010.

Population Cellular Kinetics of Lisocabtagene Maraleucel, an Autologous CD19-Directed Chimeric Antigen Receptor T-Cell Product, in Patients with Relapsed/Refractory Large B-Cell Lymphoma

Timothy R. Mack, J. Lymp, M. Dodds, 2021, Clinical Pharmacokinetics.

Rheumatoid arthritis is an independent risk factor for multi-vessel coronary artery disease: a case control study

R. Frye, S. Kopecky, C. Weyand, 2005, Arthritis research & therapy.

Hyaluronic acid, an accurate serum marker for severe hepatic fibrosis in patients with non‐alcoholic fatty liver disease

Ayako Suzuki, A. Suzuki, K. Lindor, 2005, Liver international : official journal of the International Association for the Study of the Liver.

Comparison of Efficacy and Toxicity of CD19-Specific Chimeric Antigen Receptor T-Cells Alone or in Combination with Ibrutinib for Relapsed and/or Refractory CLL

D. Maloney, C. Turtle, S. Riddell, 2018, Blood.

The hospital mortality of patients admitted to the ICU on weekends.

Bekele Afessa, Mark T Keegan, Steve G Peters, 2004, Chest.

Mortality rate and length of stay of patients admitted to the intensive care unit in July*

M. Keegan, B. Afessa, S. Peters, 2004, Critical care medicine.

Comparison of 7-day and repeated 24-hour recall of symptoms of cystic fibrosis.

C. Goss, A. Bennett, D. Patrick, 2010, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Measurement matters in the association between early adolescent depressive symptoms and body mass index.

A. McTiernan, A. Stoep, L. Richardson, 2008, General hospital psychiatry.

Preliminary Results of a Phase 1b Study (GP28331) Combining GDC-0199 (ABT-199) and Obinutuzumab in Patients with Relapsed/Refractory or Previously Untreated Chronic Lymphocytic Leukemia

Jeffrey A Jones, I. Flinn, M. Dyer, 2014 .

Values and limitations of serum aminotransferases in clinical trials of nonalcoholic steatohepatitis

J. Sauver, A. Suzuki, K. Lindor, 2006, Liver international : official journal of the International Association for the Study of the Liver.

Chronological development of elevated aminotransferases in a nonalcoholic population

A. Suzuki, K. Lindor, J. S. St. Sauver, 2005, Hepatology.

Characterizing the emotions that trigger cataplexy.

L. Krahn, M. Silber, J. Lymp, 2005, The Journal of neuropsychiatry and clinical neurosciences.

Case Report: Survey Assessment of Personal Digital Assistant Use among Trainees and Attending Physicians

Jon O. Ebbert, Thomas G. McLeod, James F. Lymp, 2003, J. Am. Medical Informatics Assoc..

Validation of parent self reported home safety practices

D. Christakis, B. Ebel, F. Rivara, 2005, Injury Prevention.

Safety and Efficacy Of Obinutuzumab (GA101) With Fludarabine/Cyclophosphamide (G-FC) Or Bendamustine (G-B) In The Initial Therapy Of Patients With Chronic Lymphocytic Leukemia (CLL): Results From The Phase 1b Galton Trial (GAO4779g)

S. O'brien, J. Pagel, J. Lymp, 2013 .

Comparison of 7-day and repeated 24-hour recall of symptoms of cystic fibrosis.

C. Goss, A. Bennett, D. Patrick, 2010, Journal of Cystic Fibrosis.

Risk Factors for Adverse Health Effects Following Hazardous Materials Incidents

D. Kovalchick, K. Kyes, W. Robertson, 2001, Journal of occupational and environmental medicine.

Lisocabtagene maraleucel in follicular lymphoma: the phase 2 TRANSCEND FL study.

K. Ardeshna, M. Dreyling, P. Borchmann, 2024, Nature medicine.

715 Hyaluronic acid, an accurate serum marker for advanced fibrosis among nonalcoholic steatohepatitis

A. Suzuki, K. Lindor, P. Angulo, 2003 .

Outpatient Treatment with Lisocabtagene Maraleucel (liso-cel) in Three Ongoing Clinical Studies in Relapsed/Refractory (R/R) B Cell Non-Hodgkin Lymphoma (NHL), Including Second-Line Transplant Ineligible Patients: Transcend NHL 001, Outreach, and PILOT

D. Maloney, T. Farazi, N. Trede, 2019, Blood.

Measurement matters in the association between early adolescent depressive symptoms and body mass index.

A. McTiernan, A. Stoep, L. Richardson, 2008, General hospital psychiatry.